Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Prosthodontics | Study protocol

Efficacy of a new membrane obturator prosthesis in terms of speech, swallowing, and the quality of life of patients with acquired soft palate defects: study protocol of the VELOMEMBRANE randomized crossover trial

Authors: Adrien Naveau, Marion Kret, Valérie Plaire, Olivier Delorme, Sébastien Marchi, Caroline de Bataille, Florent Destruhaut, Elise Arrive, Christophe Bou

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Soft palate defects created during oral cancer surgery may prevent complete palatal closure and trigger palatopharyngeal insufficiency. One current treatment employs a rigid obturator prosthesis; an extension of acrylic resin at the level of the hard palate ensures surface contact with the remaining musculature. Unfortunately, airflow escape often causes hypernasality, compromises speech intelligibility, and creates swallowing problems (including leakage of food and fluid into the nasal airway). We plan to test a new removable denture featuring a thick dental dam that serves as a membrane obturator. The principal objective of the clinical trial is a comparison of speech handicap levels after 1 month in patients with acquired velar insufficiencies who wear either the new device or a conventional, rigid obturator. The secondary objectives are between-device comparisons of the swallowing handicaps and the health-related qualities of life.

Methods

The VELOMEMBRANE trial is a superiority, open-labeled, two-way, random crossover clinical trial. Adult patients exhibiting velar or palatovelar substance loss after tumor excision and who are indicated for rigid obturator-mediated prosthetic rehabilitation will be recruited in two teaching hospitals in France. Fourteen participants will be randomly allocated to wear both prostheses for 1-month periods in either order. The new membrane obturator is a removable resin prosthesis incorporating a rigid extension that holds a dental dam to restore the soft palate. The primary outcome will be the extent of phonation-related disability (the overall score on the Voice Handicap Index [VHI]). The secondary outcomes will be the Deglutition Handicap Index and health-related quality of life scores of the European Organization for Research and Treatment of Cancer (EORTC).

Discussion

High-quality evidence will be provided to document the utility of a new medical device that may greatly improve the management and quality of life of patients with acquired velar insufficiency.

Trial registration

ClinicalTrials.​govNCT04009811. Registered on 4 July 2019
Appendix
Available only for authorised users
Literature
1.
go back to reference Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Tumeurs Solides. 2019;1:372. Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Tumeurs Solides. 2019;1:372.
3.
go back to reference Jamerson RE, White JA. Carcinoma of the soft palate and uvula. J La State Med Soc. 1991;143(2):7–9.PubMed Jamerson RE, White JA. Carcinoma of the soft palate and uvula. J La State Med Soc. 1991;143(2):7–9.PubMed
9.
go back to reference Brandão TB, Vechiato Filho AJ, Batista VE, de S, MCQ d O, Santos-Silva AR. Obturator prostheses versus free tissue transfers: a systematic review of the optimal approach to improving the quality of life for patients with maxillary defects. J Prosthet Dent. 2016;115:247–253.e4.CrossRef Brandão TB, Vechiato Filho AJ, Batista VE, de S, MCQ d O, Santos-Silva AR. Obturator prostheses versus free tissue transfers: a systematic review of the optimal approach to improving the quality of life for patients with maxillary defects. J Prosthet Dent. 2016;115:247–253.e4.CrossRef
12.
14.
go back to reference Woisard V, Bodin S, Puech M. The Voice Handicap Index: impact of the translation in French on the validation. Rev Laryngol Otol Rhinol (Bord). 2004;125(5):307–12. Woisard V, Bodin S, Puech M. The Voice Handicap Index: impact of the translation in French on the validation. Rev Laryngol Otol Rhinol (Bord). 2004;125(5):307–12.
18.
go back to reference Woisard V, Andrieux MP, Puech M. Validation of a self-assessment questionnaire for swallowing disorders (Deglutition Handicap Index). Rev Laryngol Otol Rhinol (Bord). 2006;127(5):315–25. Woisard V, Andrieux MP, Puech M. Validation of a self-assessment questionnaire for swallowing disorders (Deglutition Handicap Index). Rev Laryngol Otol Rhinol (Bord). 2006;127(5):315–25.
21.
Metadata
Title
Efficacy of a new membrane obturator prosthesis in terms of speech, swallowing, and the quality of life of patients with acquired soft palate defects: study protocol of the VELOMEMBRANE randomized crossover trial
Authors
Adrien Naveau
Marion Kret
Valérie Plaire
Olivier Delorme
Sébastien Marchi
Caroline de Bataille
Florent Destruhaut
Elise Arrive
Christophe Bou
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Prosthodontics
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06163-6

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue